Breached contraceptive coil: manufacturer must pay compensation

A German woman has won a landmark legal battle against the manufacturer of a defective copper intrauterine device (IUD), securing €5,000 in damages and reimbursement of court and legal costs after years of suffering. The Oberlandesgericht Dresden ruled in her favor following a prolonged civil trial, marking a significant victory for individuals affected by faulty contraceptive devices. The woman, who wishes to remain anonymous, described the outcome as a relief after enduring months of emotional turmoil. The case centers around a copper IUD produced by the Spanish-based company Eurogine, specifically the model Multiload “T-Safe CU 380A QL/Ancora 375” with lot number 0216. According to the plaintiff’s lawyer, this information is crucial for other women who might want to check whether they were affected by the same batch of defective products. The woman had the IUD inserted in 2017 by ProFamilia Bremen, a reproductive health center, but decided to have it removed shortly before its typical five-year expiration date. When her gynecologist attempted to remove the device, two of its arms broke off and remained inside her body. One arm later became lodged in a tampon during her menstrual cycle, while the second was never found. The woman expressed deep concern over the potential long-term effects of the broken IUD on her health, including fears that the missing parts could have migrated to other organs or impacted her future fertility. Despite seeking help from multiple specialists, including her gynecologist and the medical team at ProFamilia Bremen, she received no satisfactory answers or assistance. ProFamilia did not respond to inquiries from taz regarding the case. The woman's legal battle began after she initially won a ruling from the local district court several months earlier. However, Eurogine appealed the decision, forcing the plaintiff to endure additional months of uncertainty. Now, having secured a final judgment, she expressed pride in her personal resilience and the support she received from others. She emphasized that the case demonstrated that pharmaceutical companies can be held accountable and that women deserve proper medical care. Her attorney, representing numerous similar cases, estimates that hundreds, if not thousands, of women may have been affected by the defective IUDs. He encourages other potentially affected individuals to seek legal recourse and not be intimidated by powerful corporations. To facilitate communication among victims, the woman established an email address where others can reach out for support and solidarity. The incident highlights broader concerns about the safety and reliability of contraceptive devices, particularly those manufactured abroad. While the specific model in question has been linked to this case, the possibility of widespread issues within the same production batch raises questions about quality control and regulatory oversight. The woman’s experience underscores the need for greater transparency and accountability in the medical device industry, especially concerning products used for long-term contraception. Eurogine has not publicly commented on the court’s ruling or the allegations surrounding the defective IUDs. Meanwhile, the woman continues to advocate for other affected individuals, urging them to pursue their legal rights and demand justice. Her case serves as a precedent for others facing similar challenges, offering hope that legal action can lead to tangible outcomes in cases involving medical negligence or product defects.